← feed

Is NCT04402112 results overdue?

Yes — results are overdue. Primary completion was 2017-04-01; the FDAAA-801 reporting deadline (2018-04-01) passed 3003 days ago and no results are posted on ClinicalTrials.gov.

Efficacy and Safety of Pitavastatin in a Real-world Setting

NCT IDNCT04402112 ↗
SponsorJW Pharmaceutical (INDUSTRY)
Phase
StatusCOMPLETED
Primary completion2017-04-01 (ACTUAL)
Reporting deadline2018-04-01 (completion + 365d)
Days overdue3003
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 3848c768941ff949… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04402112. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →